1887
  1. Home
  2. A-Z Publications
  3. Qatar Medical Journal
  4. Volume 2022, Issue 1
  5. Article
Volume 2022, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Melioidosis is a severe disease that can affect humans and animals. It is caused by which is an environmental aerobic gram negative bacteria. Despite being endemic in Southeast Asia and Northern Australia, many cases have been reported from different regions, including the Middle East. This is the third imported case of from Oman in a 46-year-old Indian male with left knee septic arthritis in less than three weeks after arrival in Oman. He underwent open arthrotomy, and his synovial fluid culture grew a bacteria with dry, pink colonies that were oxidase positive, susceptible to amoxicillin–clavulanic, identified by API NE as , and confirmed by molecular tests. This single case report highlights the urgent need to increase molecular diagnostic capacity and improve public health surveillance while maintaining a one health tripartite approach.

© 2022 Al Salti, Al Subhi, Al-Jardani, Al-Rashdi, Almayahi, licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2022.13
2022-03-04
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2022/1/qmj.2022.13.html?itemId=/content/journals/10.5339/qmj.2022.13&mimeType=html&fmt=ahah

References

  1. Limmathurotsakul D, Golding N, Dance DAB, Messina JP, Pigott DM, Moyes CL, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016; 1:(1):15008. doi:10.1038/nmicrobiol.2015.8.
     [Google Scholar]
  2. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005; 18:(2):383-416. doi:10.1128/CMR.18.2.383-416.2005.
     [Google Scholar]
  3. Meumann EM, Cheng AC, Ward L, Currie BJ. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis. 2012; 54:(3):362-9. doi:10.1093/cid/cir808.
     [Google Scholar]
  4. Alhatmi H, Alharbi A, Bosaeed M, Aldosary O, Aljohani S, Alalwan B, et al. Melioidosis: case reports of confirmed Burkholderia pseudomallei in Saudi Arabia. J Infect Public Health. 2020; 13:(5):824-6. doi:10.1016/j.jiph.2020.01.310.
     [Google Scholar]
  5. Dance DA, Limmathurotsakul D. Global burden and challenges of melioidosis. Trop Med Infect Dis. 2018; 3:(1):E13. doi:10.3390/tropicalmed3010013.
     [Google Scholar]
  6. Advisory Committee on Dangerous Pathogens. The approved list of biological agents. Health and Safety Executive [Internet]. 2021 [cited]. Available from: https://www.hse.gov.uk/pubns/misc208.pdf, accessed Feb 9th 2022.
     [Google Scholar]
  7. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010; 4:(11):e900. doi:10.1371/journal.pntd.0000900.
     [Google Scholar]
  8. Tamtami NA, Khamis F, Al-Jardani A. Imported case of melioidosis in Oman: case report. Oman Med J. 2017; 32:(1):62-5. doi:10.5001/omj.2017.11.
     [Google Scholar]
  9. Al-Kindi N, Shah PH, Naryan A, Al-Abri S, Jardani AA. Burkholderia pseudomallei: Public health and occupational risk of exposure due to an imported case of melioidosis. Am J Med Case Rep. 2019; 7:(11):292-6. doi:10.12691/ajmcr-7-11-8.
     [Google Scholar]
  10. Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg. 2008; 102:(1):S1-4. doi:10.1016/S0035-9203(08)70002-6.
     [Google Scholar]
  11. Foong YC, Tan M, Bradbury RS. Melioidosis: a review. Rural Remote Health. 2014; 14:(4):2763. doi:10.22605/RRH2763.
     [Google Scholar]
  12. Morse LP, Smith J, Mehta J, Ward L, Cheng AC, Currie BJ. Osteomyelitis and septic arthritis from infection with Burkholderia pseudomallei: a 20-year prospective melioidosis study from northern Australia. J Orthop. 2013; 10:(2):86-91. doi:10.1016/j.jor.2013.04.001.
     [Google Scholar]
  13. Teparrakkul P, Tsai JJ, Chierakul W, Gerstenmaier JF, Wacharaprechasgu T, Piyaphanee W, et al. Rheumatological manifestations in patients with melioidosis. Southeast Asian J Trop Med Public Health. 2008; 39:(4):649-55.
     [Google Scholar]
  14. Kosuwon W, Taimglang T, Sirichativapee W, Jeeravipoolvarn P. Melioidotic septic arthritis and its risk factors. J Bone Joint Surg Am. 2003; 85:(6):1058-61. doi:10.2106/00004623-200306000-00011.
     [Google Scholar]
  15. Hemarajata P, Baghdadi JD, Hoffman R, Humphries RM. Burkholderia pseudomallei: challenges for the clinical microbiology laboratory. J Clin Microbiol. 2016; 54:(12):2866-73. doi:10.1128/JCM.01636-16.
     [Google Scholar]
  16. Alwarthan SM, Aldajani AA, Al Zahrani IM, Bukhari HA. Melioidosis: Can tropical infections present in nonendemic areas? A case report and review of the literature. Saudi J Med Med Sci. 2018; 6:(2):108-11. doi:10.4103/sjmms.sjmms_118_16.
     [Google Scholar]
  17. Wernery R, Kinne J, Haydn-Evans J, Ul-Haq A. Melioidosis in a seven year old camel, a new disease in the United Arab Emirates (UAE). Journal of Camel Practice and Research. 1997; 4:(4):141-3.
     [Google Scholar]
  18. Doker TJ, Quinn CL, Salehi ED, Sherwood JJ, Benoit TJ, Elrod MG, et al. Fatal Burkholderia pseudomallei infection initially reported as a Bacillus species, Ohio, 2013. Am J Trop Med Hyg. 2014; 91:(4):743-6. doi:10.4269/ajtmh.14-0172.
     [Google Scholar]
  19. Lau SKP, Sridhar S, Ho CC, Chow WN, Lee KC, Lam CW, et al. Laboratory diagnosis of melioidosis: past, present and future. Exp Biol Med. 2015; 240:(6):742-51. doi:10.1177/1535370215583801.
     [Google Scholar]
  20. Inglis TJJ, Merritt A, Chidlow G, Aravena-Roman M, Harnett G. Comparison of diagnostic laboratory methods foridentification of Burkholderia pseudomallei. J Clin Microbiol. 2005; 43:(5):2201-6. doi:10.1128/JCM.43.5.2201-6.2005.
     [Google Scholar]
  21. Kiratisin P, Santanirand P, Chantratita N, Kaewdaeng S. Accuracy of commercial systems for identification of Burkholderia pseudomallei versus Burkholderia cepacia. Diagn Microbiol Infect Dis. 2007; 59:(3):277-81. doi:10.1016/j.diagmicrobio.2007.06.013.
     [Google Scholar]
  22. Kaestli M, Richardson LJ, Colman RE, Tuanyok A, Price EP, Bowers JR, et al. Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol. 2012; 50:(6):2059-62. doi:10.1128/JCM.06737-11.
     [Google Scholar]
  23. Holland RD, Wilkes JG, Rafii F, Sutherland JB, Persons CC, Voorhees KJ, et al. Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 1996; 10:(10):1227-32. doi:10.1002/(SICI)1097-0231(19960731)10:10 < 1227:AID-RCM659>3.0.CO;2-6.
     [Google Scholar]
  24. Krásný L, Hynek R, Hochel I. Identification of bacteria using mass spectrometry techniques. Int J Mass Spectrom. 2013;353:67-79. doi:10.1016/j.ijms.2013.04.016.
     [Google Scholar]
  25. Welker M, Moore ERB. Applications of whole-cell matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry in systematic microbiology. Syst Appl Microbiol. 2011; 34:(1):2-11. doi:10.1016/j.syapm.2010.11.013.
     [Google Scholar]
  26. Gassiep I, Armstrong M, Norton RE. Identification of Burkholderia pseudomallei by use of the Vitek mass spectrometer. J Clin Microbiol. 2019; 57:(5):e00081-19. doi:10.1128/JCM.00081-19.
     [Google Scholar]
  27. Dingle TC, Butler-Wu SM, Abbott AN. Accidental exposure to Burkholderia pseudomallei in the laboratory in the era of matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol. 2014; 52:(9):3490-1. doi:10.1128/JCM.01238-14.
     [Google Scholar]
  28. Hodgson K, Engler C, Govan B, Ketheesan N, Norton R. Comparison of routine bench and molecular diagnostic methods in identification of Burkholderia pseudomallei. J Clin Microbiol. 2009; 47:(5):1578-80. doi:10.1128/JCM.02507-08.
     [Google Scholar]
  29. Trinh TT, Hoang TS, Tran DA, Trinh VT, Gohler A, Nguyen TT, et al. A simple laboratory algorithm for diagnosis of melioidosis in resource-constrained areas: a study from north-central Vietnam. Clin Microbiol Infect. 2018; 24:(1):84.e1-84.e4. doi:10.1016/j.cmi.2017.07.029.
     [Google Scholar]
  30. CDC. Bioterrorism agents/diseases (by category). Emergency preparedness and response [Internet]. 2019 May 15 [cited 2021 Jan 6]. Available from: https://emergency.cdc.gov/agent/agentlist-category.asp.
     [Google Scholar]
  31. Melikyan G, Badawi M, Akhtar N, Elsetouhy AH. Case of paraspinal collection due to Burkholderia pseudomallei. BMJ Case Rep. 2013;2013:bcr2013201447. doi:10.1136/bcr-2013-201447.
     [Google Scholar]
  32. Barbour EK, Nabbut NH, Hamadeh SK, Al-Nakhli HM. Bacterial identity and characteristics in healthy and unhealthy respiratory tracts of sheep and calves. Vet Res Commun. 1997; 21:(6):421-30. doi:10.1023/A:1005855318665.
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2022.13
Loading
Burkholderia pseudomallei Septic Arthritis of the Knee Joint: Report of a Third Imported Case in Oman
Qatar Medical Journal 2022, 13 (2022); https://doi.org/10.5339/qmj.2022.13
/content/journals/10.5339/qmj.2022.13
/content/journals/10.5339/qmj.2022.13
Loading

Data & Media loading...

  • Article Type: Case Report
Keyword(s): Amoxicillin–clavulanic acid, Bacterial infections, Burkholderia pseudomallei, Melioidosis, Oman and Septic arthritis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error